


Ask a doctor about a prescription for APIDRA 100 units/mL injectable solution in cartridge
Package Leaflet: Information for the User
Apidra100 Units/ml Solution for Injection in Cartridge
Insulin Glulisine
Read all of this leaflet carefully before you start using this medicine because it contains important information for you. The instructions for use of the insulin pen are provided with your insulin pen. Read them carefully before using your medicine.
Contents of the Package Leaflet
Apidra is an antidiabetic agent used to reduce high blood sugar levels in patients with diabetes mellitus. It can be administered to adults, adolescents, and children from 6 years of age. Diabetes mellitus is a disease in which your body does not produce enough insulin to control blood sugar levels.
It is produced by biotechnology. It has a rapid onset of action within 10-20 minutes and a short duration of action, around 4 hours.
Do not use Apidra
Warnings and Precautions
Apidra in cartridges is only intended for injection under the skin with a reusable pen (see also section 3). Consult your doctor if you need to inject insulin by another method.
Consult your doctor, pharmacist, or nurse before starting to use Apidra.
Follow carefully the instructions for dosing, monitoring (blood tests), diet, and physical activity (work and exercise) as indicated by your doctor.
Special patient groups
If you have liver or kidney problems, consult your doctor as you may need a lower dose.
There is not enough clinical information on the use of Apidra in children under 6 years of age.
Changes in the skin at the injection site.
The injection site should be rotated to avoid changes in the skin, such as lumps under the skin. Insulin may not work as well if injected into a lumpy area (see How to use Apidra). Contact your doctor if you are currently injecting into a lumpy area before starting to inject into a different area. Your doctor may advise you to check your blood sugar levels more closely and adjust your insulin or the dose of your other antidiabetic medications.
Travel
Before traveling, consult your doctor. You may need to consult about
Illnesses and injuries
The management of your diabetes may require special care in the following situations:
If you have type 1 diabetes (insulin-dependent diabetes mellitus), do not stop taking your insulin and follow a sufficient carbohydrate diet. Always inform the people in charge of your care or treatment that you need insulin.
Some patients with long-standing type 2 diabetes mellitus and previous heart disease or stroke who were treated with pioglitazone and insulin developed heart failure. Inform your doctor as soon as possible if you experience symptoms of heart failure such as unusual shortness of breath or rapid weight gain or localized swelling (edema).
Using Apidra with other medicines
Some medicines produce changes in blood sugar levels (increase, decrease, or both depending on the situation). In each case, it may be necessary to adjust your insulin dose to avoid blood sugar levels that are too low or too high. Be careful when starting to take another medicine and also when stopping it.
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines. Ask your doctor before taking a medicine if it can affect your blood sugar level and what measures you should take, if any.
Among the medicines that can cause a decrease in your blood sugar level (hypoglycemia) are:
Among the medicines that can cause an increase in your blood sugar level (hyperglycemia) are:
Your blood sugar level may rise or fall if you take:
Pentamidine (used to treat some parasitic infections) can cause hypoglycemia, which can sometimes be followed by hyperglycemia.
Beta-blockers, like other sympatholytic medicines (such as clonidine, guanethidine, and reserpine), can mask or completely suppress the early warning symptoms that could help you recognize hypoglycemia.
If you are not sure if you are taking any of these medicines, ask your doctor or pharmacist.
Using Apidra with alcohol
Your blood sugar levels may rise or fall if you drink alcohol.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.
Tell your doctor if you are planning to have a baby or if you are already pregnant. Your insulin dose may need to be changed during pregnancy and after delivery. Careful control of your diabetes and prevention of hypoglycemia are important for the health of your baby.
There are limited or no data on the use of Apidra in pregnant women.
If you are breastfeeding, consult your doctor as you may need to adjust your insulin dose and diet.
Driving and using machines
Your ability to concentrate or react may be reduced if:
Be aware of this possible problem, considering all situations that may pose a risk to you or others (such as driving a vehicle or using machines).
You should ask your doctor for advice on your ability to drive if:
Important information about some of the ingredients of Apidra
This medicine contains less than 1 mmol (23 mg) of sodium per dose, which is essentially "sodium-free".
Apidra contains metacresol
Apidra contains metacresol, which may cause allergic reactions.
Dose
Follow exactly the administration instructions of this medicine indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Your doctor will determine the dose of Apidra you need based on your lifestyle and the results of your blood sugar (glucose) tests and previous insulin treatment.
Apidra is a short-acting insulin. Your doctor may advise you to use it in combination with an intermediate-acting, long-acting, basal insulin, or with tablets used to treat high blood sugar levels.
If you switch from another insulin to insulin glulisine, your dose may need to be adjusted by your doctor.
Many factors can influence your blood sugar level. You should be aware of these factors so that you can react correctly to changes in your blood sugar level and avoid it becoming too high or too low. See the box at the end of the leaflet for more information.
Method of administration
Apidra is injected under the skin (subcutaneously).
Your doctor will advise you on which area of the skin to inject Apidra. Apidra can be injected into the abdominal wall, thigh, or upper arm, or by continuous infusion into the abdominal wall. The effect will be slightly faster if the insulin is injected into your abdomen. As with other insulins, the injection and infusion sites within an injection area (abdomen, thigh, or upper arm) should be rotated from one injection to another.
Frequency of administration
Apidra should be administered shortly (0-15 minutes) before or shortly after meals.
Instructions for correct use
How to handle cartridges
Apidra in cartridges is only intended for injection under the skin with a reusable pen. Consult your doctor if you need to inject insulin by another method.
To ensure you get the exact dose, Apidra cartridges should only be used with the following pens:
In your country, only some of these pens may be marketed.
The pen must be used as recommended in the information provided by the device manufacturer.
The manufacturer's instructions for using the pen should be followed carefully to load the cartridge, attach the needle, and administer the insulin injection.
Before inserting the cartridge into the reusable pen, the cartridge should be stored at room temperature for 1 to 2 hours.
Inspect the cartridge before use. It should only be used if the solution is clear, colorless, and has no visible particles.
It should not be shaken or mixed before use.
After inserting a new cartridge:
You should check that your insulin pen is working properly before injecting the first dose (see the instructions for use of your pen).
Special precautions before injection
Air bubbles should be removed from the cartridge before injection (see the instructions for use of the pen). Empty cartridges should not be refilled.
To prevent any contamination, the reusable pen should only be used by you.
Problems with the insulin pen?
Please consult the manufacturer's instructions for the pen.
If your insulin pen is damaged or not working properly (due to mechanical problems), it should be discarded and a new insulin pen used.
If you use more Apidra than you should
If you forget to use Apidra
If you stop using Apidra
This could lead to severe hyperglycemia (very high blood sugar levels) and ketoacidosis (increased acid in the blood because the body breaks down fat instead of sugar). Do not stop using Apidra without consulting your doctor; he will tell you what to do.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.
Mix-ups between insulins
Always check the insulin label before each injection to avoid mix-ups between Apidra and other insulins.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
Severe Adverse Effects
Hypoglycemia (low blood sugar levels) can be very severe.Hypoglycemia is a very frequently observed adverse effect (it can affect more than 1 in 10 patients).
Hypoglycemia (low blood sugar levels) means that you do not have enough sugar in your blood.If your blood sugar level drops too low, you may lose consciousness. Severe hypoglycemia can cause brain damage and can be life-threatening. If you experience symptoms of low blood sugar, act immediatelyto raise your blood sugar level. See the box at the end of this leaflet, where you will find more important information about hypoglycemia and its treatment.
If you experience the following symptoms, contact your doctor immediately:
Systemic allergic reactionsare infrequently observed adverse effects (they can affect up to 1 in 100 patients).
Generalized allergy to insulin:related symptoms may include large-scale skin reactions (skin rash and itching all over the body), severe swelling of the skin or mucous membranes (angioedema), difficulty breathing, drop in blood pressure with rapid heartbeat and sweating.
Hyperglycemia (high blood sugar levels) means that there is too much sugar in the blood.
The frequency of hyperglycemia cannot be estimated. If your blood sugar level is too high, this indicates that you may need more insulin than you have injected. This can be severe if your blood sugar level becomes very high.
For more information on the signs and symptoms of hyperglycemia, see the box at the end of this leaflet.
Other Adverse Effects
If insulin is injected too frequently in the same place, the fatty tissue can shrink (lipoatrophy) or become thicker (lipohypertrophy) (it can affect up to 1 in 1,000 people). Lumps under the skin can also occur due to the accumulation of a protein called amyloid (cutaneous amyloidosis; the frequency of this is unknown). Insulin may not work very well if injected into a lumpy area. Change the injection site to help avoid these skin changes.
Frequent Adverse Effects(can affect up to 1 in 10 patients)
Reactions at the injection site (such as redness, intense pain, itching, hives, swelling, or inflammation) can be experienced. These reactions can also spread around the injection site. Most minor reactions to insulin are usually resolved within a few days or weeks.
Adverse Effectswhose frequency cannot be estimated from the available data
A significant change (improvement or worsening) in the control of your blood sugar level can cause a temporary worsening of your vision. If you have proliferative retinopathy (an eye disease related to diabetes), severe hypoglycemic attacks can cause temporary loss of vision.
Reporting of Adverse Effects
If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect that is not listed in this leaflet. You can also report them directly through the national reporting system included in Appendix V. By reporting adverse effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date stated on the carton and on the label of the cartridge after CAD/EXP. The expiration date is the last day of the month indicated.
Unopened cartridges
Store in a refrigerator (between 2°C and 8°C).
Do not freeze.
Do not place Apidra near the freezer compartment or next to a cold accumulator. Keep the cartridge in the outer packaging to protect it from light.
Cartridges in use
Cartridges in use (in the insulin pen) can be stored for a maximum of 4 weeks below 25°C, protected from direct heat or direct light, and should not be stored in a refrigerator. Do not use this medicine after this period.
Do not use this medicine if it is not colorless and transparent.
Medicines should not be disposed of through wastewater or household waste. Ask your pharmacist how to dispose of the packaging and medicines that are no longer needed. This will help protect the environment.
Apidra Composition
Product Appearance and Package Contents
Apidra 100 Units/ml injectable solution in a cartridge is a clear, colorless, particle-free aqueous solution.
Each cartridge contains 3 ml of solution (300 U). There are packs of 1, 3, 4, 5, 6, 8, 9, and 10 cartridges of 3 ml. Not all pack sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder:
Sanofi-Aventis Deutschland GmbH
D-65926 Frankfurt am Main
Germany
Manufacturer:
Sanofi-Aventis Deutschland GmbH
Industriepark Höchst, D-65926 Frankfurt
Germany
You can request more information about this medicine by contacting the local representative of the Marketing Authorization Holder.
België/Belgique/Belgien Sanofi Belgium Tél/Tel: +32 (0)2 710 54 00 | Luxembourg/Luxemburg Sanofi Belgium Tél/Tel: +32 (0)2 710 54 00 (Belgique/Belgien) |
| Magyarország SANOFI-AVENTIS Zrt. Tel.: +36 1 505 0050 |
Ceská republika Sanofi s.r.o. Tel: +420 233 086 111 | Malta Sanofi S.r.l. Tel: +39 02 39394275 |
Danmark Sanofi A/S Tlf: +45 45 16 70 00 | Nederland Sanofi B.V. Tel: +31 20 245 4000 |
Deutschland Sanofi-Aventis Deutschland GmbH Tel.: 0800 52 52 010 Tel. from abroad: +49 69 305 21 131 | Norge sanofi-aventis Norge AS Tlf: +47 67 10 71 00 |
Eesti Swixx Biopharma OÜ Tel: +372 640 10 30 | Österreich sanofi-aventis GmbH Tel: +43 1 80 185 – 0 |
Ελλ?δα Sanofi-Aventis Μονοπρ?σωπη AEBE Τηλ: +30 210 900 16 00 | Polska Sanofi Sp. z o.o. Tel.: +48 22 280 00 00 |
España sanofi-aventis, S.A. Tel: +34 93 485 94 00 | Portugal Sanofi - Produtos Farmacêuticos, Lda. Tel: +351 21 35 89 400 |
France Sanofi Winthrop Industrie Tél: 0 800 222 555 Call from abroad: +33 1 57 63 23 23 | România Sanofi Romania SRL Tel: +40 (0) 21 317 31 36 |
Hrvatska Swixx Biopharma d.o.o. Tel: +385 1 2078 500 Ireland sanofi-aventis Ireland Ltd. T/A SANOFI Tel: +353 (0) 1 403 56 00 | Slovenija Swixx Biopharma d.o.o. Tel: +386 1 235 51 00 |
Ísland Vistor hf. Sími: +354 535 7000 | Slovenská republika Swixx Biopharma s.r.o. Tel: +421 2 208 33 600 |
Italia Sanofi S.r.l. Tel: 800 13 12 12 (technical questions) 800 536389 (other questions) | Suomi/Finland Sanofi Oy Puh/Tel: +358 (0) 201 200 300 |
Κ?προς C.A. Papaellinas Ltd. Τηλ: +357 22 741741 | Sverige Sanofi AB Tel: +46 (0)8 634 50 00 |
Latvija Swixx Biopharma SIA Tel: +371 6 616 47 50 | United Kingdom(Northern Ireland) sanofi-aventis Ireland Ltd. T/A SANOFI Tel: +44 (0) 800 035 2525 |
Lietuva Swixx Biopharma UAB Tel: +370 5 236 91 40 |
Date of the Last Revision of this Leaflet:
Other Source of Information
Detailed information about this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu/
HYPERGLYCEMIA AND HYPOGLYCEMIA
Always carry something sweet with you (at least 20 grams).
Always carry some information that indicates you are a person with diabetes.
HYPERGLYCEMIA (high blood sugar levels)
If you have a very high blood sugar level (hyperglycemia), you may not have injected enough insulin.
Why does hyperglycemia occur?
Some examples are:
Warning symptoms of hyperglycemia
Thirst, increased need to urinate, fatigue, dry skin, redness of the face, loss of appetite, low blood pressure, rapid heartbeat, and the presence of glucose and ketone bodies in the urine. Stomach pain, deep and rapid breathing, drowsiness, or even loss of consciousness can be signs of a severe condition (ketoacidosis) due to lack of insulin.
What to do in case of hyperglycemia?
You must analyze your blood sugar level and your urine acetone level as soon as any of the above symptoms occur. Severe hyperglycemia or ketoacidosis must always be treated by a doctor, usually in a hospital.
HYPOGLYCEMIA (low blood sugar levels)
If your blood sugar level drops too low, you may lose consciousness. Severe hypoglycemia can cause a heart attack or brain damage and can be life-threatening. You should usually be able to recognize when your blood sugar level is dropping too low to take the necessary measures.
Why does hypoglycemia occur?
Some examples are:
It is also more likely that hypoglycemia will occur if:
Warning symptoms of hypoglycemia
Examples of symptoms that indicate your blood sugar level is dropping too low or too quickly: sweating, damp and sticky skin, anxiety, rapid heartbeat, high blood pressure, palpitations, and irregular heartbeat. These symptoms often occur before the symptoms of low blood sugar in the brain.
Examples of symptoms that indicate there is a low level of sugar in the brain: headaches, intense hunger, nausea, vomiting, fatigue, drowsiness, sleep disorders, restlessness, aggressive behavior, concentration problems, altered reactions, depression, confusion, speech disorders (sometimes, complete loss of speech), visual disturbances, tremors, paralysis, tingling sensations (paresthesias), numbness and tingling sensations in the mouth area, dizziness, loss of self-control, inability to take care of oneself, convulsions, and loss of consciousness.
The first warning symptoms of hypoglycemia ("warning symptoms") may change, weaken, or be absent if:
In this case, you may develop severe hypoglycemia (and even lose consciousness) before you realize the problem. Always be familiar with your warning symptoms. If necessary, more frequent blood sugar analysis can help identify mild hypoglycemic episodes that would otherwise go unnoticed. If you are not sure you can recognize your warning symptoms, avoid situations (such as driving a car) that could put you or others in danger due to hypoglycemia.
What to do if hypoglycemia occurs?
Tell your family, friends, and people close to you the following:
If you are unable to swallow or lose consciousness, you will need an injection of glucose or glucagon (a medication that increases blood sugar levels). These injections are justified even if you are not sure you have hypoglycemia.
It is recommended to analyze your blood sugar level immediately after ingesting glucose to confirm that you actually have hypoglycemia.
The average price of APIDRA 100 units/mL injectable solution in cartridge in October, 2025 is around 46.97 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for APIDRA 100 units/mL injectable solution in cartridge – subject to medical assessment and local rules.